Bhopal: AIIMS Bhopal is stepping into the future of healthcare with a new partnership with Erasmus Medical Centre, Rotterdam, Netherlands. Together, they will work on cutting-edge research in pharmacogenomics – the science of how our genes affect the way drugs work.For patients, the collaboration promises more personalized treatments. Rather than relying on a single drug for everyone, genetic testing can help doctors identify which drug will work best for each individual, leading to safer prescriptions, fewer side effects, and faster recoveries.This research aims to evaluate scalability, clinical utility, and health-economic impact with the goal of making treatments more personalized and cost-effective.A high-level delegation from the Erasmus Medical Center led by Professor Peter J van der Spek, Head of Clinical Bioinformatics, visited AIIMS Bhopal and met Dr Madhavanand Kar, Director of the Institute. During the meeting, a letter of intent to strengthen academic cooperation between the two institutions was presented. The proposed project worth over Rs 10 crore will be led by Dr Shubham Atal, Additional Professor, Department of Pharmacology, AIIMS Bhopal, who will serve as the Principal Investigator. Professor (Dr) Madhavananda Kar welcomed the initiative, while Professor Peter J. Van der Spek highlighted the potential of building a strong India-Dutch partnership in precision medicine.